Providers looking to enhance CI products must consider the effect on systems and pricing, and whether further underwriting is required. Julie Hopkins explores how cover can be retrospectively amended.
When insurers reprice or relaunch critical illness (CI) products they will often add new conditions. Reasons for doing this could include offering additional benefits to policyholders, remaining competitive and matching the Association of British Insurers (ABI) standard definitions. With the advent of ABI+ definitions, insurers may also take the opportunity to move to these as they ‘enhance’ standard ABI definitions by omitting certain clauses or exclusions. The question of whether it is possible to add retrospective cover to existing CI policies is an interesting one. It is worth dis...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes